Sun Yat-sen University Cancer Center (SYSUCC) was established in 1964 and is one of the four earliest tumor hospitals in China. It is one of the affiliated hospitals of the prestigious Sun Yat-sen University. Located in the city of Guangzhou, SYSUCC is leading the way on a national frontier. It is the largest integrated cancer center in the whole of southern China for cancer care, education, research and prevention. SYSUCC’s mission is to help people prevent and cure cancer.
SYSUCC has been awarded many prestigious titles
* National Key Disciplines (Oncology)
* State Key Laboratory (SKL) of Oncology in South China
* Key Laboratory of Oncology of the Ministry of Education
* Key Laboratory of Guangdong Province
* National Clinical Study Center for Anticancer Drugs
* Cancer Hospital of Chinese Traditional and Western Medicine
* Doctoral Degree Authorization Center
* Post-doctoral Station of Scientific Research
SYSUCC is also a supporting institute for the Guangdong Cancer Center, the Guangdong Esophageal Cancer Research Institute and the Guangdong Anti-cancer Association.
SYSUCC is a modern medical service provider with 1600 ward beds, 34 clinical departments, 8 administrative offices and 2 research departments. Equipped with state of the art medical technology, SYSUCC has a premier radiation therapy center and a da Vinci robot for minimally invasive surgeries. Moreover, SYSUCC has never stopped improving its quality of service pushing the boundaries of research and patient care. The responsibility system of chief expert for a single cancer disease was first applied in our center and the multi-disciplinary diagnosis and treatment plan for different cancer diseases were designed by our specialists. Under the effort of the physicians and nurses at SYSUCC, 22 clinical research achievements are internationally recognized and have been included in the National Comprehensive Cancer Network (NCCN) guidelines.
SYSUCC provides a comprehensive range of healthcare services for cancer diagnosis and treatment including surgery, radiotherapy, chemotherapy, interventional therapy, immunotherapy, gene therapy and Traditional Chinese Medicine (TCM).
Some of SYSUCC's clinical departments:
* Medical Oncology
* Radiation Oncology
* Anesthesia, ICU
* Surgery: Head and neck, Thoracic, Hepatobiliary, Gastric and Pancreatic, Colorectal, Neurosurgery, Urology
* Tumor biology: Pathology, Clinical Laboratory, Molecular Diagnostics
* Imaging: Interventional Radiology and Medical Imaging, Endoscopy and Laser, Ultrasound, Nuclear Medicine
* Dedicated units: Breast Cancer, Gynecological Cancer, Nasopharyngeal Carcinoma
* Traditional Chinese Medicine
* Pediatric Oncology
* VIP Department
* Clinical Nutrition
* Preventive Medicine
Research and New Drug Development
As one of the earliest cancer hospitals founded in China, SYSUCC has always closely combined its clinical and research attributes, ranking top two in the Chinese Hospital of Scientific Impact Ranking. The State Key Laboratory (SKL) of Oncology in South China was founded in March 2005 by the Ministry of Science and Technology in China. This laboratory is integrated into SYSUCC. Its activities cover a broad spectrum in oncology from basic to translational and clinical research.
Since 2001, a tumor tissue bank has been established to provide researchers a dynamic collection of biological samples (blood, fresh tissue, bone marrow, biopsy and other fluids) for cancer research. To help bridge the gap between basic drug research and clinical applications, a Clinical Trial Center (CTC) was also setup to assist physicians and scientists to test new therapies. It includes a National Clinical Study Center for Anticancer Drugs and a National Key Laboratory of Anti-cancer Drug Development. The CTC is China Food and Drug Administration (CFDA) certified. Its core services range from clinical research management, Phase I research, medical statistics, academic research consultation, clinical trial regulation and technical guideline training, feasibility assessment and investigator identification, regulatory affairs, finance and contract management, data management, and clinical epidemiology.
SYSUCC houses the editorial office of Cancer Communications (CC), formerly the Chinese Journal of Cancer (CJC). Entirely published in English, CC disseminates original research, reviews, perspectives, supplements, and spotlights in all areas of cancer research.
In 2014, the CC became Science Citation Indexed (SCI), and its impact factor ranks the first among the national journals of Oncology. In the past four years, it has been continuously awarded with the Outstanding S&T Journals of China. Additionally, SYSUCC disseminates Cancer Prevention - the popular science newspaper for cancer prevention in China.
In 2003, SYSUCC became a sister institution of the University of Texas MD Anderson Cancer Center (MDACC) -- a top-ranking cancer research institute and hospital in the United States. SYSUCC also has numerous international partners all around the world, including the Karolinska Institutet, the University of Warwick, the Erasmus Medical Center, among others. Together, we combine different approaches, views and novel research in our fight to conquer cancer.
The SYSUCC Radiation Center has 10 Linear Accelerators and 13 Treatment Rooms, treating up to 1,000 Inpatients and 5,000 Outpatients. Evolving through the years, the SYSUCC has been equipped with the following technologies since 2010: IGRT, VMAT and SBRT Technologies, in addition to the existing 3DCRT, IMRT and 4 DCT.
A new campus of 1 million square feet is currently under construction inLuo Gang District - Guangzhou city, including a Proton Therapy center.
Last update: Sep 2018